EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SEHLM was filed as Word mark on 02/20/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/07/2018.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 017841826 |
| Application date | February 20, 2018 |
| Publication date | March 29, 2018 |
| Entry date | July 7, 2018 |
| Expiration date | February 20, 2028 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia; pharmaceutical preparations for the diagnosis, prevention and/or treatment of endocrine diseases and disorders, and gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and/or treatment of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain and Parkinson's disease; pharmaceutical preparations for the diagnosis, prevention and/or treatment of Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11017841826